RAPT Therapeutics (RAPT) Enterprise Value: 2020-2024
Historic Enterprise Value for Therapeutics (RAPT) over the last 5 years, with Dec 2024 value amounting to $55.2 million.
- Therapeutics' Enterprise Value fell 92.06% to $55.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $55.2 million, marking a year-over-year decrease of 25.84%. This contributed to the annual value of $55.2 million for FY2024, which is 92.06% down from last year.
- As of Q4 2024, Therapeutics' Enterprise Value stood at $55.2 million, which was up 299.05% from -$27.7 million recorded in Q3 2024.
- In the past 5 years, Therapeutics' Enterprise Value ranged from a high of $895.6 million in Q4 2021 and a low of -$27.7 million during Q3 2024.
- Moreover, its 3-year median value for Enterprise Value was $364.7 million (2022), whereas its average is $314.9 million.
- Per our database at Business Quant, Therapeutics' Enterprise Value surged by 139.81% in 2021 and then tumbled by 107.18% in 2024.
- Quarterly analysis of 5 years shows Therapeutics' Enterprise Value stood at $373.5 million in 2020, then soared by 139.81% to $895.6 million in 2021, then slumped by 61.68% to $343.2 million in 2022, then surged by 102.78% to $695.9 million in 2023, then plummeted by 92.06% to $55.2 million in 2024.
- Its Enterprise Value was $55.2 million in Q4 2024, compared to -$27.7 million in Q3 2024 and -$8.4 million in Q2 2024.